Genetic Variants in CETP Increase Risk of Intracerebral Hemorrhage

Global Lipids Genetics Consortium; International Stroke Genetics Consortium; Christopher D. Anderson; Guido J. Falcone; Chia-Ling Phuah; Farid Radmanesh; H. Bart Brouwers; Thomas W. K. Battey; Alessandro Biffi; Gina M. Peloso; Dajiang J. Liu; Alison M. Ayres; Joshua N. Goldstein; Anand Viswanathan; Steven M. Greenberg; Magdy Selim; James F. Meschia; Devin L. Brown; Bradford B. Worrall; Scott L. Silliman; David L. Tirschwell; Matthew L. Flaherty; Peter Kraft; Jeremiasz M. Jagiella; Helena Schmidt; Björn M. Hansen; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano; Koen M. Van Nieuwenhuizen; Catharina J.M. Klijn; Kristiina Rannikmae; Neshika Samarasekera; Rustam Al-Shahi Salman; Catherine L. Sudlow; Ian J. Deary; Andrea Morotti; Alessandro Pezzini; Joanna Pera; Andrzej Urbanik; Alexander Pichler; Christian Enzinger; Bo Norrving; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Jaume Roquer; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt

doi:10.1002/ana.24780

Genetic Variants in CETP Increase Risk of Intracerebral Hemorrhage

Global Lipids Genetics Consortium, International Stroke Genetics Consortium, Christopher D. Anderson, Guido J. Falcone, Chia-Ling Phuah, Farid Radmanesh, H. Bart Brouwers, Thomas W. K. Battey, Alessandro Biffi, Gina M. Peloso, Dajiang J. Liu, Alison M. Ayres, Joshua N. Goldstein, Anand Viswanathan, Steven M. Greenberg, Magdy Selim, James F. Meschia, Devin L. Brown, Bradford B. Worrall, Scott L. SillimanDavid L. Tirschwell, Matthew L. Flaherty, Peter Kraft, Jeremiasz M. Jagiella, Helena Schmidt, Björn M. Hansen, Jordi Jimenez-Conde, Eva Giralt-Steinhauer, Roberto Elosua, Elisa Cuadrado-Godia, Carolina Soriano, Koen M. Van Nieuwenhuizen, Catharina J.M. Klijn, Kristiina Rannikmae, Neshika Samarasekera, Rustam Al-Shahi Salman, Catherine L. Sudlow, Ian J. Deary, Andrea Morotti, Alessandro Pezzini, Joanna Pera, Andrzej Urbanik, Alexander Pichler, Christian Enzinger, Bo Norrving, Joan Montaner, Israel Fernandez-Cadenas, Pilar Delgado, Jaume Roquer, Arne Lindgren, Agnieszka Slowik, Reinhold Schmidt

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

Objective: In observational epidemiologic studies, higher plasma high‐density lipoprotein cholesterol (HDL‐C) has been associated with increased risk of intracerebral hemorrhage (ICH). DNA sequence variants that decrease cholesteryl ester transfer protein (CETP) gene activity increase plasma HDL‐C; as such, medicines that inhibit CETP and raise HDL‐C are in clinical development. Here, we test the hypothesis that CETP DNA sequence variants associated with higher HDL‐C also increase risk for ICH.

Methods: We performed 2 candidate‐gene analyses of CETP. First, we tested individual CETP variants in a discovery cohort of 1,149 ICH cases and 1,238 controls from 3 studies, followed by replication in 1,625 cases and 1,845 controls from 5 studies. Second, we constructed a genetic risk score comprised of 7 independent variants at the CETP locus and tested this score for association with HDL‐C as well as ICH risk.

Results: Twelve variants within CETP demonstrated nominal association with ICH, with the strongest association at the rs173539 locus (odds ratio [OR] = 1.25, standard error [SE] = 0.06, p = 6.0 × 10⁻⁴) with no heterogeneity across studies (I² = 0%). This association was replicated in patients of European ancestry (p = 0.03). A genetic score of CETP variants found to increase HDL‐C by ∼2.85mg/dl in the Global Lipids Genetics Consortium was strongly associated with ICH risk (OR = 1.86, SE = 0.13, p = 1.39 × 10⁻⁶).

Interpretation: Genetic variants in CETP associated with increased HDL‐C raise the risk of ICH. Given ongoing therapeutic development in CETP inhibition and other HDL‐raising strategies, further exploration of potential adverse cerebrovascular outcomes may be warranted.

Original language	English
Pages (from-to)	730–740
Number of pages	11
Journal	Annals of Neurology
Volume	80
Issue number	5
Early online date	22 Sept 2016
DOIs	https://doi.org/10.1002/ana.24780
Publication status	Published - Nov 2016

Access to Document

10.1002/ana.24780Licence: Creative Commons: Attribution (CC-BY)

Anderson_et_al-2016-Annals_of_NeurologyFinal published version, 169 KBLicence: Creative Commons: Attribution (CC-BY)

Cite this

Global Lipids Genetics Consortium, International Stroke Genetics Consortium, Anderson, C. D., Falcone, G. J., Phuah, C.-L., Radmanesh, F., Bart Brouwers, H., Battey, T. W. K., Biffi, A., Peloso, G. M., Liu, D. J., Ayres, A. M., Goldstein, J. N., Viswanathan, A., Greenberg, S. M., Selim, M., Meschia, J. F., Brown, D. L., Worrall, B. B., ... Schmidt, R. (2016). Genetic Variants in CETP Increase Risk of Intracerebral Hemorrhage. Annals of Neurology, 80(5), 730–740. https://doi.org/10.1002/ana.24780

@article{0d12e6ac57b2495e811ae9cb2d0eaaeb,

title = "Genetic Variants in CETP Increase Risk of Intracerebral Hemorrhage",

abstract = "Objective: In observational epidemiologic studies, higher plasma high‐density lipoprotein cholesterol (HDL‐C) has been associated with increased risk of intracerebral hemorrhage (ICH). DNA sequence variants that decrease cholesteryl ester transfer protein (CETP) gene activity increase plasma HDL‐C; as such, medicines that inhibit CETP and raise HDL‐C are in clinical development. Here, we test the hypothesis that CETP DNA sequence variants associated with higher HDL‐C also increase risk for ICH.Methods: We performed 2 candidate‐gene analyses of CETP. First, we tested individual CETP variants in a discovery cohort of 1,149 ICH cases and 1,238 controls from 3 studies, followed by replication in 1,625 cases and 1,845 controls from 5 studies. Second, we constructed a genetic risk score comprised of 7 independent variants at the CETP locus and tested this score for association with HDL‐C as well as ICH risk.Results: Twelve variants within CETP demonstrated nominal association with ICH, with the strongest association at the rs173539 locus (odds ratio [OR] = 1.25, standard error [SE] = 0.06, p = 6.0 × 10−4) with no heterogeneity across studies (I2 = 0%). This association was replicated in patients of European ancestry (p = 0.03). A genetic score of CETP variants found to increase HDL‐C by ∼2.85mg/dl in the Global Lipids Genetics Consortium was strongly associated with ICH risk (OR = 1.86, SE = 0.13, p = 1.39 × 10−6).Interpretation: Genetic variants in CETP associated with increased HDL‐C raise the risk of ICH. Given ongoing therapeutic development in CETP inhibition and other HDL‐raising strategies, further exploration of potential adverse cerebrovascular outcomes may be warranted.",

author = "{Global Lipids Genetics Consortium} and {International Stroke Genetics Consortium} and Anderson, {Christopher D.} and Falcone, {Guido J.} and Chia-Ling Phuah and Farid Radmanesh and {Bart Brouwers}, H. and Battey, {Thomas W. K.} and Alessandro Biffi and Peloso, {Gina M.} and Liu, {Dajiang J.} and Ayres, {Alison M.} and Goldstein, {Joshua N.} and Anand Viswanathan and Greenberg, {Steven M.} and Magdy Selim and Meschia, {James F.} and Brown, {Devin L.} and Worrall, {Bradford B.} and Silliman, {Scott L.} and Tirschwell, {David L.} and Flaherty, {Matthew L.} and Peter Kraft and Jagiella, {Jeremiasz M.} and Helena Schmidt and Hansen, {Bj{\"o}rn M.} and Jordi Jimenez-Conde and Eva Giralt-Steinhauer and Roberto Elosua and Elisa Cuadrado-Godia and Carolina Soriano and {Van Nieuwenhuizen}, {Koen M.} and Klijn, {Catharina J.M.} and Kristiina Rannikmae and Neshika Samarasekera and {Al-Shahi Salman}, Rustam and Sudlow, {Catherine L.} and Deary, {Ian J.} and Andrea Morotti and Alessandro Pezzini and Joanna Pera and Andrzej Urbanik and Alexander Pichler and Christian Enzinger and Bo Norrving and Joan Montaner and Israel Fernandez-Cadenas and Pilar Delgado and Jaume Roquer and Arne Lindgren and Agnieszka Slowik and Reinhold Schmidt",

year = "2016",

month = nov,

doi = "10.1002/ana.24780",

language = "English",

volume = "80",

pages = "730–740",

journal = "Annals of Neurology",

issn = "0364-5134",

publisher = "Wiley",

number = "5",

}

Global Lipids Genetics Consortium, International Stroke Genetics Consortium, Anderson, CD, Falcone, GJ, Phuah, C-L, Radmanesh, F, Bart Brouwers, H, Battey, TWK, Biffi, A, Peloso, GM, Liu, DJ, Ayres, AM, Goldstein, JN, Viswanathan, A, Greenberg, SM, Selim, M, Meschia, JF, Brown, DL, Worrall, BB, Silliman, SL, Tirschwell, DL, Flaherty, ML, Kraft, P, Jagiella, JM, Schmidt, H, Hansen, BM, Jimenez-Conde, J, Giralt-Steinhauer, E, Elosua, R, Cuadrado-Godia, E, Soriano, C, Van Nieuwenhuizen, KM, Klijn, CJM, Rannikmae, K, Samarasekera, N , Al-Shahi Salman, R , Sudlow, CL , Deary, IJ, Morotti, A, Pezzini, A, Pera, J, Urbanik, A, Pichler, A, Enzinger, C, Norrving, B, Montaner, J, Fernandez-Cadenas, I, Delgado, P, Roquer, J, Lindgren, A, Slowik, A & Schmidt, R 2016, 'Genetic Variants in CETP Increase Risk of Intracerebral Hemorrhage', Annals of Neurology, vol. 80, no. 5, pp. 730–740. https://doi.org/10.1002/ana.24780

TY - JOUR

T1 - Genetic Variants in CETP Increase Risk of Intracerebral Hemorrhage

AU - Global Lipids Genetics Consortium

AU - International Stroke Genetics Consortium

AU - Anderson, Christopher D.

AU - Falcone, Guido J.

AU - Phuah, Chia-Ling

AU - Radmanesh, Farid

AU - Bart Brouwers, H.

AU - Battey, Thomas W. K.

AU - Biffi, Alessandro

AU - Peloso, Gina M.

AU - Liu, Dajiang J.

AU - Ayres, Alison M.

AU - Goldstein, Joshua N.

AU - Viswanathan, Anand

AU - Greenberg, Steven M.

AU - Selim, Magdy

AU - Meschia, James F.

AU - Brown, Devin L.

AU - Worrall, Bradford B.

AU - Silliman, Scott L.

AU - Tirschwell, David L.

AU - Flaherty, Matthew L.

AU - Kraft, Peter

AU - Jagiella, Jeremiasz M.

AU - Schmidt, Helena

AU - Hansen, Björn M.

AU - Jimenez-Conde, Jordi

AU - Giralt-Steinhauer, Eva

AU - Elosua, Roberto

AU - Cuadrado-Godia, Elisa

AU - Soriano, Carolina

AU - Van Nieuwenhuizen, Koen M.

AU - Klijn, Catharina J.M.

AU - Rannikmae, Kristiina

AU - Samarasekera, Neshika

AU - Al-Shahi Salman, Rustam

AU - Sudlow, Catherine L.

AU - Deary, Ian J.

AU - Morotti, Andrea

AU - Pezzini, Alessandro

AU - Pera, Joanna

AU - Urbanik, Andrzej

AU - Pichler, Alexander

AU - Enzinger, Christian

AU - Norrving, Bo

AU - Montaner, Joan

AU - Fernandez-Cadenas, Israel

AU - Delgado, Pilar

AU - Roquer, Jaume

AU - Lindgren, Arne

AU - Slowik, Agnieszka

AU - Schmidt, Reinhold

PY - 2016/11

Y1 - 2016/11

N2 - Objective: In observational epidemiologic studies, higher plasma high‐density lipoprotein cholesterol (HDL‐C) has been associated with increased risk of intracerebral hemorrhage (ICH). DNA sequence variants that decrease cholesteryl ester transfer protein (CETP) gene activity increase plasma HDL‐C; as such, medicines that inhibit CETP and raise HDL‐C are in clinical development. Here, we test the hypothesis that CETP DNA sequence variants associated with higher HDL‐C also increase risk for ICH.Methods: We performed 2 candidate‐gene analyses of CETP. First, we tested individual CETP variants in a discovery cohort of 1,149 ICH cases and 1,238 controls from 3 studies, followed by replication in 1,625 cases and 1,845 controls from 5 studies. Second, we constructed a genetic risk score comprised of 7 independent variants at the CETP locus and tested this score for association with HDL‐C as well as ICH risk.Results: Twelve variants within CETP demonstrated nominal association with ICH, with the strongest association at the rs173539 locus (odds ratio [OR] = 1.25, standard error [SE] = 0.06, p = 6.0 × 10−4) with no heterogeneity across studies (I2 = 0%). This association was replicated in patients of European ancestry (p = 0.03). A genetic score of CETP variants found to increase HDL‐C by ∼2.85mg/dl in the Global Lipids Genetics Consortium was strongly associated with ICH risk (OR = 1.86, SE = 0.13, p = 1.39 × 10−6).Interpretation: Genetic variants in CETP associated with increased HDL‐C raise the risk of ICH. Given ongoing therapeutic development in CETP inhibition and other HDL‐raising strategies, further exploration of potential adverse cerebrovascular outcomes may be warranted.

AB - Objective: In observational epidemiologic studies, higher plasma high‐density lipoprotein cholesterol (HDL‐C) has been associated with increased risk of intracerebral hemorrhage (ICH). DNA sequence variants that decrease cholesteryl ester transfer protein (CETP) gene activity increase plasma HDL‐C; as such, medicines that inhibit CETP and raise HDL‐C are in clinical development. Here, we test the hypothesis that CETP DNA sequence variants associated with higher HDL‐C also increase risk for ICH.Methods: We performed 2 candidate‐gene analyses of CETP. First, we tested individual CETP variants in a discovery cohort of 1,149 ICH cases and 1,238 controls from 3 studies, followed by replication in 1,625 cases and 1,845 controls from 5 studies. Second, we constructed a genetic risk score comprised of 7 independent variants at the CETP locus and tested this score for association with HDL‐C as well as ICH risk.Results: Twelve variants within CETP demonstrated nominal association with ICH, with the strongest association at the rs173539 locus (odds ratio [OR] = 1.25, standard error [SE] = 0.06, p = 6.0 × 10−4) with no heterogeneity across studies (I2 = 0%). This association was replicated in patients of European ancestry (p = 0.03). A genetic score of CETP variants found to increase HDL‐C by ∼2.85mg/dl in the Global Lipids Genetics Consortium was strongly associated with ICH risk (OR = 1.86, SE = 0.13, p = 1.39 × 10−6).Interpretation: Genetic variants in CETP associated with increased HDL‐C raise the risk of ICH. Given ongoing therapeutic development in CETP inhibition and other HDL‐raising strategies, further exploration of potential adverse cerebrovascular outcomes may be warranted.

U2 - 10.1002/ana.24780

DO - 10.1002/ana.24780

M3 - Article

SN - 0364-5134

VL - 80

SP - 730

EP - 740

JO - Annals of Neurology

JF - Annals of Neurology

IS - 5

ER -

Genetic Variants in CETP Increase Risk of Intracerebral Hemorrhage

Abstract / Description of output

Access to Document

Other files and links

Fingerprint

Brain imaging and cognitive ageing in the Lothian Birth Cohort 1936: III

RA2661 Centre for Cognitive Ageing and Cognitive Epidemiology Phase 2. Main Budget.

Cite this

Genetic Variants in CETP Increase Risk of Intracerebral Hemorrhage

Abstract / Description of output

Access to Document

Other files and links

Fingerprint

Projects

Brain imaging and cognitive ageing in the Lothian Birth Cohort 1936: III

RA2661 Centre for Cognitive Ageing and Cognitive Epidemiology Phase 2. Main Budget.

Cite this